Study Stopped
Withdrawn due to business reasons
Assessment of Prevident Sodium Fluoride 1.1% Toothpaste Using an Intra-oral Remineralization-demineralization Model
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
This is a double blind, cross-over, controlled clinical trial utilizing thirty (30) adults to evaluate remineralization of early caries lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2016
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 4, 2016
CompletedFirst Posted
Study publicly available on registry
March 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFebruary 21, 2019
February 1, 2019
3 months
March 4, 2016
February 19, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Mineral Change (delta Z)
Tooth samples of human enamel are placed in a retainer and worn by each study subject. Enamel block samples will be x-rayed and analyzed for mineral level (volume % of micrometer of lesions, vol % µm) before being placed in the retainer. These baseline values will be compared with the post use delta mineral change ( ΔZ).
Baseline
Mineral Change (delta Z)
Tooth samples of human enamel are placed in a retainer and worn by each study subject. After 2 weeks of brushing while wearing the study oral retainer, samples from the retainer will be x-rayed and analyzed for mineral level (volume % of micrometer of lesions, vol % µm). These post use values will be compared to the baseline values to give a delta mineral change ( ΔZ).
2 weeks (from Baseline)
Study Arms (3)
Fluoride Free toothpaste
PLACEBO COMPARATORFluoride free (0%), silica based toothpaste
1.1% Fluoride toothpaste
EXPERIMENTALPrevident 5000 Plus, silica based toothpaste
0.243% Fluoride Toothpaste
ACTIVE COMPARATORsilica based fluoride toothpaste
Interventions
Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait 1 minute before rinsing with water.
Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait 1 minute before rinsing with water.
Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait 1 minute before rinsing with water.
Eligibility Criteria
You may qualify if:
- Male and/or female subjects 18 to 50 years inclusive
- Minimum of 20 natural uncrowned teeth (excluding third molars) must be present
- Willing to wear retainer 24 hours per day
- No active, unrestored cavities
- Have normal salivary flow rate (stimulated and unstimulated flow of ≥0.7 ml/min and ≥ 0.2 ml/min respectively) ascertained from a preliminary sialometry
- Available throughout entire study
- Willing to use only assigned products for oral hygiene throughout the duration of the study
- Must give written informed consent
- Must be in good general health
- No known history of allergy to personal care/consumer products or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study
You may not qualify if:
- Advanced periodontal disease
- Medical condition which requires premedication prior to dental visits/procedures
- Not enough teeth to secure the oral retainer
- Diseases of the soft or hard oral tissues
- Wear an Orthodontic retainer(s)
- Impaired salivary function
- Current use drugs that can affect salivary flow
- Use antibiotics one (1) month prior to or during this study
- Positive urine test for pregnancy (a urine pregnancy test will be performed on female subjects of child-bearing potential)
- Participate in another clinical study one (1) week prior to the start of the washout period or during this 9-week study period
- Use tobacco products
- Allergic history to common toothpaste ingredients
- Immune compromised individuals (HIV, AIDS, immuno-suppressive drug therapy) as determined by review of medical history
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bennet Amaechi, PhD, DDS
University of Texas
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2016
First Posted
March 15, 2016
Study Start
March 1, 2016
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
February 21, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share